John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients.

Zoé Léonie Elise van KempenC E LeursA de VriesA VennegoorT RispensM P WattjesJ Killestein

Published in: European journal of neurology (2017)

Higher natalizumab concentrations do not explain the increased JCV seroconversion rate in natalizumab treated patients.

Keyphrases